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Summary.-Post-mortem studies suggest that liver metastases obtain the majority
of their nutrition from the hepatic artery; however, cytotoxic arterial perfusion with
or without hepatic-artery ligation has not proved entirely successful as a therapeutic
regime.
In this study we have measured blood flow into colorectal liver metastases using
xenon-133 (133Xe) clearance in patients undergoing surgery for colorectal cancer.
Pre-operative measurements after direct parenchymal injection gave a mean flow
of 41-5 i 22.5 ml/min/100 g which after hepatic arterial occlusion perfusion, was
reduced to a mean of5o% of the pre-occlusion value.
Dynamic blood-flow studies using the gamma camera were performed in the post-
operative period by administration of 133Xe into both hepatic arterial and portal
venous catheters. The initial distribution images indicated a predominant arterial
perfusion to the metastases, but after hepatic-artery ligation, portal-vein perfusion
to the metastases was statistically significantly increased.
Hence, a compensatory haemodynamic mechanism exists which may account for
the poor results of hepatic-artery ligation and perfusion alone.
THE LIVER contains metastases in
about one-third to one-half of fatal
cases of colorectal malignance (Brown &
Warren, 1938; Willis, 1948; Cedermark
et al., 1977). Goligher (1941) reviewed
893 cases coming to laparotomy and
showed an incidence of 11.5%, whereas
more recently Bengmark & Hafstrom
(1969) found an incidence of hepatic
metastases at laparotomy of 24.5%
with a mean survival of 5 1 months.
Other series have confirmed the bleak
prognosis associated with colorectal liver
secondaries (Pestana et al., 1964; Jaffe et
al., 1968; Taylor, 1978) It has been
estimated that as many as 50% of tum-
ours will sooner or later give rise to liver
metastases (Bengmark & Hafstrom, 1969).
The growth and development of liver
metastases are dependent upon their
blood supply. It is known that micro-
metastases reach the liver through the
portal venous system by invasion of the
mesenteric veins (Brown & Warren, 1938;
Dukes, 1.940; Fisher & Turnbull, 1955;
Fisher & Fisher, 1959; Baserga et al.,
1960). While the developing metastases
are small they continue to obtain their
nutrition from the portal vein, but as
they enlarge the blood supply is thought
to be chiefly arterial (Ackerman, 1972).
Breedis & Young (1954) studied blood
flow into liver metastases in great detail,
using injection of coloured dyes, chiefly
in post-mortem specimens. Following in-
jection into the hepatic artery the tumours
were coloured, as was the adjacent normal
liver, but the main bulk of the liver
remained free. The conclusion was that
the hepatic artery was the chief blood
supply to liver metastases. Microscopic
examination showed that the thin-walled
portal vein (of all sizes) was occluded by
the invading tumour cells so that pigment
was prevented from reaching the metas-
tases from portal vein injection.
These theories have led over the years
to the development of hepatic artery
ligation and various forms of cytotoxic
perfusion techniques in the treatment ofI. TAYLOR, R. BENNETT AND S. SHERRIFF
multiple colorectal liver metastases (Bren-
nan et al., 1963; Almersjo et al., 1968,
1972; Watkins et at., 1970; Murray-Lyon
et al., 1970; Ansfield et al., 1971; Fortner
et al., 1973;Ansfield, 1975).Unfortunately,
the results of these techniques in im-
proving symptom-free survival have been
particularly disappointing and unpredict-
able.
In this study we have measured blood
flow into liver metastases, both at initial
laparotomy and in the subsequent post-
operative period, in patients undergoing
surgery for colorectal cancer. Blood flow
has been measured by the clearance of
the inert radioactive gas xenon-133 admin-
istered into the liver. In this way, the
relative perfusion characteristics of both
normal liver and liver metastases before
and after hepatic-artery ligation have
been made. Since 133Xe is cleared at
cellular level this method gives an indi-
cation ofnutritive perfusion.
MATERIALS AND METHODS
Pre-operative measurements.-These were
obtained by direct parenchymal injection of
133Xe. Eight patients with macroscopically
normal livers (controls), and 6 patients with
extensive liver metastases were studied. The
control subjects were patients undergoing
cholecystectomy or vagotomy and pyloro-
plasty. The studies on patients with liver
metastases were performed before palliative
colorectal resections.
133Xe dissolved in saline (0.1-0.15 ml
100-15 ,Ci) was directly injected into the
liver substance with a fine needle. The
needle was held inplace for 30 s afterinjection
to minimize escape of Xe via the needle
tract. It was essential to ensure that no air
bubbles entered the injectate since the Xe
would preferentially enter the air bubbles
rather than the venous return. The same
type of needle was used for each injection.
A 1 in iodide detector with a multihole
collimator was carefully placed over the area
and held in a steady and constant position
for 10 min. It was placed in such a way that
it viewed the liver but not the lung, since
this is the pathway of exit for the Xe. The
detector was connected via a scaler ratemeter
to a chart recorder with a chart speed of
5 cm/min. The time constant was 3 s and the
count maintained at 6000 ct/s. Throughout
the procedure the anaesthetic system was on
an open circuit to allow the Xe to escape.
Recordings were obtained from the normal
liver and from both normal liver and tumour
in patients with metastatic deposits. Further
recordings were obtained whilst the hepatic
artery was occluded between fingers.
Post-operative measurements.-Dynamic
blood-flow studies were performed on 17
patients who were included in a trial to
assess different perfusion techniques for the
treatment of multiple colorectal metastases
noted at the time of initial laparotomy. In
each case the primary tumour was resected
and the patients were allocated to receive
either no perfusion treatment, hepatic-
artery ligation and distal cytotoxic perfusion
(HAL + P), hepatic-artery ligation and dis-
tal cytotoxic perfusion with portal vein
perfusion through the umbilical vein (HAL +
P + UVP or umbilical-vein perfusion alone
(UVP). The cytotoxic agent used was 5-
fluorouracil and was given as a continuous
perfusion into the umbilical vein, or in the
case of the hepatic artery, into the distal
vasculature after proximal ligation and
division of the vessel.
Before removal of the catheters (on the
tenth post-operative day) the patients were
positioned supine under the gamma camera
so that the anterior surface of the liver was
in the field of view of the camera. Two mCi
of 133Xe dissolved in saline was injected
into the catheters and flushed through with
20 ml saline.
The rate of clearance of the 133Xe from
the liver and metastases was recorded using
an on-line computer system which collected
the integrated counts over the field of view
for 60 consecutive periods of 10 s. The
resulting images were stored on magnetic
disc. Each image, which consisted ofan array
of 64 x 64 elements, was reduced to an
8 x 8 array by summing over 64 adjacent
points so that each new element represented
a 3-5 x 3*5 cm area. Any element which
represented areas within the field ofview but
outside the liver and which also contained
radioactivity (e.g. the catheter and the
lungs) were excluded from the subsequent
analysis.
Analysis of blood flow.-Blood flow was
expressed as liver perfusion in ml/min/100 g
ofliver tissue by multiplying the exponential
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rate constant of the fast component (k) by
the partition coefficient (A), i.e. blood flow =
kAlOO.
The dynamic blood-flow images from the
gamma camera were compared with 99mTc
sulphur-colloid liver scans.
RESULTS
Pre-operative bloodflow
Normal liver.-In 7 of the 8 patients
studied a double-exponential clearance
curve was obtained. The blood flow
ranged from 36.6 to 123 mls/min/100 g
(mean 73-4 i 33-7 (Fig. 1). Temporary
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FIG. 1.-Liver blood flow (in ml/min/100 g)
obtained from both normal liver and liver
metastases after direct parenchymal in-
jection.
hepatic-artery occlusion with the fingers in
2 patients produced a fall in blood flow to
65% of the pre-occluded value.
Metastatic nodules.-Clearance after in-
jection into metastatic nodules also gave
the typical double-exponential curve. The
mean values ranged between 7 and 78
ml/min/100 g (mean 41-5 i 22-5). After
hepatic artery occlusion with the fingers,
perfusion through the nodules fell to a
mean of 5% of the pre-occluded value
(Fig. 2). On release of the occlusion, blood
flow returned to pre-occlusion values.
Post-operative (dynamic studies)
In each of the patients studied, a
double-exponential clearance curve was
apparent, both from the metastases and
from the segments ofnormal liver. Analy-
sis of the data showed 3 different types of
image in the region of the metastases
after 133Xe administration.
(a) The initial distribution image showed
where the isotope went to and reflected
the distribution of blood vessels.
(b) The perfusion image was correlated
by the computer and showed the areas
of greater perfusion as the darker image.
(c) The retention image was also com-
puter generated and showed regions in
which the Xe clearance was prolonged
for any reason (i.e. poorer perfusion
through the tissue under study).
Hepatic-artery ligation and distal cyto-
toxic perfusion (6 patients).-The results
in this group of patients were difficult to
assess, since the hepatic artery was
ligated and injection therefore made into
the distal vasculature. In all patients the
initial distribution was mainly to the liver
metastases, and the hepatic-artery reten-
tion was high. The distribution image in
such a patient is given in Fig. 3.
Portal-veinperfusion alone (5patients).-
In all patients the initial distribution of
133Xe was to normal liver only (Fig. 4). In
only 1 patient did a portal-vein perfusion
image occur in a metastasis, and in this
patient the retentionimage was prolonged,
suggesting poor perfusion within the
metastasis.
Hepatic-artery ligation with cytotoxic
perfusion and umbilical-vein perfusion (6
patients).-The distribution images in
this group of patients were particularly
interesting. After injection into the hep-
atic-artery catheter, distribution was to
the second deposits rather than normal
liver (Fig. 5). This was associated in 4
patients with delayed retention images,
suggesting poor perfusion.
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FIG. 2.-Clearance curve after direct injection into a metastasis. Hepatic-artery occlusion with the fingers caused complete cessation ofperfusion into the metastasis. On release ofocclusion the blood flow returned to its pre-occluded rate. The graph reads from right to left.
However, in this group of patients,
in whom the hepatic artery was ligated,
injection of 133Xe into the portal-vein
catheter produced distribution to both
normal perfusion was even to both metas-
tases and normal liver. In 4 patients, the
retention image was poor, indicating
increased blood flow.
DISCUSSION
Two separate studies have been carried
out to measure liver blood flow to differ-
ent areas of the human liver, both with
and without established liver secondaries.
The method of measurement uses the
clearance of 133Xe which is administered
either by direct parenchymal injection
into normal liver and adjacent liver
metastases at laparotomy, or by intra-
portal and/or intrahepatic injections. Cer-
tain aspects of each technique require
amplification.
Direct injection of 133Xe has previously been used to measure skeletal blood flow
(Lassen, 1964) as well as liver blood flow
(Gelin et al., 1968). It has the advantage of
simplicity and convenience, but suffers
from the drawback of measurements
only at laparotomy. However, it is a
method which has proved both reliable
at low flow levels and reproducible.
After injection, the Xe diffuses rapidly through the liver and very shortly after
injection is in diffusion equilibrium with
the tissues. However, blood leaving the
capillaries and entering the venous return
is also in equilibrium with the tissue,
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FIG. 3. (a) The pre-operative 99mTc
sulphur-colloid liver scan, showing liver
metastases as filling defects. (b) After 133Xe
injection into the hepatic artery, perfusion
is chiefly to the metastases and surround-
ing normal liver.
hence injected Xe is in equilibrium with
the liver and venous blood leaving the
liver. The detector sees all the Xe injected
into the liver. The blood flowing through
the liver picks up the Xe and carries it
away in the venous return, out of sight
of the detector. Since the Xe is virtually
completely expired when it reaches the
lungs, there is little recirculation, hence
the activity seen by the detector declines
progressively. Gelin et al. (1968) have
reported that measurements of blood
flow obtained by direct injection of
133Xe into liver parenchyma gave a
simple exponential curve. However, in
this study a typical double-exponential
FIG. 4.-Distribution image after 133Xe in-
jection into the portal-vein catheter.
Note the perfusion to normal liver but
minimal perfusion into the metastases.
curve in all but one patient has been
obtained, suggesting that whatever the
technique of 133Xe administration there
is a double-exponential curve. Mackenzie
et al. (1976) have shown that by screening
out extra-hepatic radioactivity, the true
intrahepatic clearance is mono-exponen-
tial.
Certain technical features also require
emphasis. Firstly, small volumes of 133Xe
are injected slowly, so that diffusion
equilibrium is rapid and care is taken to
ensure that no air bubbles are injected,
since Xe will preferentially enter the
air rather than the venous return. Second-
ly, the anaesthetic system must always
be an open one, to allow the 133Xe to
escape rather than be recirculated. Finally,
since the lung is thepathwayofexit for the
Xe, the detector must be placed in such
awaythatit seesthe liver but does not see
the lung. It is conceivable that the anaes-
theticagentswillaffectliverbloodflowafter
direct injection and absolute values can-
not be compared with the values in the
conscious subject. Nevertheless, all the
parameters will be altered similarly in all
patients and the values obtained from
each area ofthe liver are similarly affected.
The calculated blood flow will depend
substantially on the partition coefficient
753
i
M.m mmI. TAYLOR, R. BENNETT AND S. SHERRIFF
(a)
(b)
(c)
. ...
II
FiG. 5.-(a) The pre-operative 99mTc
sulphur-colloid liver scan showing liver
metastases as filling defects. (b) After 133Xe
injection into the hepatic artery, perfusion
is again chiefly to the metastases. (c) Injec-
tion into the portal vein also produced a
distribution image to the liver metastases.
ofthe tissue under study. In our measure-
ments of partition coefficient by the
technique of Veall & Mallett (1965) the
values varied very little between normal
and metastatic liver tissue.
Followingdirect 133Xeinjection,tempor-
ary occlusion ofthe hepatic artery reduced
the blood flow in the normal liver to
65% of the unoccluded values, whereas
flow to the large metastatic nodules was
reduced to a mean of 5% of the pre-
occluded value. On release of occlusion
the blood flow returned to pre-occlusion
values, which suggests both reliability
and reproducibility of the technique.
This confirms previous observations on
the predominant hepatic arterial blood
supply to liver metastases (Breedis and
Young, 1954; Healey, 1965; Lien &
Ackerman, 1970; Gelin et at., 1968).
Several interesting observations were
made in the dynamic blood-flow studies
on the livers with widespread metastases.
Firstly, in patients with portal-vein
catheters alone, the blood flow was pre-
dominantly to normal liver, and perfusion
withinthesecondarydepositswas minimal.
In the one patient with portal-vein per-
fusion, the '33Xe retention image was
prolonged suggesting a very sluggish blood
flow. However, in patients in whom
the main hepatic artery was ligated,
portal-vein injection of 133Xe produced
distribution to secondary deposits in each
of the 6 patients studied. There was clear
perfusion to liver metastases in 5 patients,
as well as to normal liver, and in 4
patients the retention image was poor,
indicating increased blood flow.
Thus, after hepatic-artery ligation the
portal-vein circulation appears to increase
to the liver metastases almost as though
there were a compensatory haemodynamic
situation. Clearly the hepatic artery, when
patent, contributes the majority of nutri-
tion to liver metastases, with a minimal
amount from the portal vein. But after
occlusion of the main hepatic artery, the
portal vein is able to increase its contribu-
tion to the metastases. This may help
to explain the initial improvement after
hepatic artery ligation reported in several
series(Plengvanitetal., 1967; Balasegaram,
1972) with diminution in size of liver
metastases. However,asubsequentincrease
usually occurs with gradual clinical de-
terioration of the patient. Presumably
this is due to the portal vein supplying
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nutrition to the metastases which leads to
tumour growth.
Hencethere maybegoodhaemodynamic
reasons for combining hepatic-artery liga-
tion and perfusion with portal-vein perfu-
sion. It may be ofvalue to speculate on the
possible compensatory factors which in-
crease portal-vein perfusion to metastases
after hepatic-artery ligation. It has been
suggested that the thin-walled portal
vein is compressed by the larger metas-
tases and this occlusion explains the lack
of portal flow to metastases (Lien &
Ackerman, 1970). However, since the
portal vein is able to increase its contribu-
tion after hepatic artery ligation, this is
unlikely to be the entire explanation.
The situation is comparable to the estab-
lishment of a "collateral" circulation. In
other words, when the chief blood supply
is compromised by deliberate occlusion
of the hepatic artery, the portal vein is
"stimulated" in some way to increase its
contribution to the metastases. Lien &
Ackerman (1970), studying implanted
tumours in rats, showed that shunting
from the hepatic artery to portal vein did
occur within the tumour plexus, and that
after hepatic-artery ligation the tumour-
plexus circulation was filled via the portal
vein.
Studies in normal liver have shown a
widespread variation in blood flow be-
tween one area of the liver and another,
and this variation alters from minute to
minute (Sherriff et al., 1977). It would
appear reasonable, therefore, to suggest
that the portal blood flow has the capa-
city to alter its rate substantially, presum-
ably in response to various physiological
situations. Hence, it may be that hepatic-
artery occlusion is one of the many
stimuli which produces an altered portal
blood flow throughout the liver and liver
metastases.
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